Citation Impact
1 by Nobel laureates 2 from Science/Nature 54 standout
Citing Papers
The landscape of nanoparticle-based siRNA delivery and therapeutic development
2024 Standout
Chemically Modified Platforms for Better RNA Therapeutics
2024 Standout
Works of Lorah Perlee being referenced
A Phase 2, Open-Label Study Evaluating the Safety and Efficacy of Combination Pozelimab and Cemdisiran Therapy in Patients with Paroxysmal Nocturnal Hemoglobinuria Who Switch from Eculizumab
2022
Interim Analysis of an Open-Label, Ascending-Dose, Phase 1 Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of the Subcutaneously Administered Human Monoclonal Antibody Pozelimab in Combination with Single Doses of the Subcutaneously Administered siRNA Cemdisiran in Healthy Volunteers
2021
Author Peers
| Author | Immunology | Hematology | RNMI | Molecular Biology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Lorah Perlee | 165 | 56 | 158 | 234 | 33 | 650 | |
| Kamil Kraus | 1 | 73 | 9 | 361 | |||
| Raphael Alhadeff | 1 | 7 | 16 | 204 | 18 | 303 | |
| Jennifer A. Irvin | 12 | 2 | 65 | 28 | 581 | ||
| Lavinia Robba | 2 | 109 | 10 | 553 | |||
| Klaus Schmitt | 6 | 8 | 218 |
All Works
Login with ORCID to disown or claim papers
Loading papers...